On October 4, 2023, Novartis successfully executed the spin-off of Sandoz by distributing Sandoz shares as a dividend-in-kind to Novartis shareholders and American Depositary Receipts (ADRs) holders. Sandoz shares are now listed on the SIX Swiss Exchange.
Kellerhals Carrard advised the founders and Neustark, a pioneering climate technology company based in Berne and known for its innovative solution to permanently sequester CO₂ from the air in recycled mineral waste, in its landmark
Bär & Karrer served as legal counsel to Customs Support Group, a company within the Castik Capital portfolio, in its recent acquisition of Zollimpex, a division of BKM Customs and Consulting (BKM). Zollimpex is
Homburger advised Tolremo therapeutics on the extension of its Series A financing round, bringing the total amount raised to USD 39 million (CHF 34.1 million). BioMedPartners led the round with participation from a new investor, Pierre Fabre
NSF has acquired the four trust companies Sedes Treuhand Anstalt, Central-TreuhandInstitut, Cura Treuinstitut and Gestions Anstalt as of September 15, 2023. This secures thelong-term future of the Sedes Group. This acquisition will strengthen NSF position as one
PBM Avocats is continuing to expand in French-speaking Switzerland. The Geneva law firm has announced the arrival of Henri Corboz (pictured), who will strengthen the firm’s banking and finance regulatory and compliance practice. As
DKSH Holding, a renowned market expansion services provider and trusted partner for companies looking to grow in Asia and beyond, announced the conversion of its existing CHF 150 million revolving credit loan into a sustainability-linked revolving
Fidinam Group Holding and Swiss Finance & Property Group (SFP) have acquired minority stakes and entered into a strategic partnership in relation to Erop Generation, a new real estate group founded in May 2023 by Andrea
Walder Wyss has advised co-led investors Swisscanto and imec.xpand in connection with Nagi Bioscience’s Series A Financing round in the amount of CHF 12.4 million. The Swiss life sciences startup has secured an oversubscribed
Nicolas Wehrli has joined Loyens & Loeff ‘s Zurich office as a partner in the corporate and M&A practice group. Wehrli has extensive experience representing clients in complex M&A, private equity
